NGM BIOPHARMACEUTICALS INC
(62921N105)
Fondsberichterstattung Bestände von NGM BIOPHARMACEUTICALS INC gemäß 13F Anmeldungen
| Firmenname | Gehaltene Aktien / Nennbetrag | Marktwert | Möglichkeit | Berichtszeitraum | Gültigkeitsdatum |
|---|---|---|---|---|---|
| RHO Capital Partners Inc | 3,766,667 | $55,144k | Jun 30, 2019 | Aug 13, 2019 | |
| Rock Springs Capital Management LP | 351,100 | $5,140k | Jun 30, 2019 | Aug 14, 2019 | |
| Jasper Ridge Partners LP | 349,000 | $5,109k | Jun 30, 2019 | Aug 9, 2019 | |
| Healthcor Management LP | 342,579 | $5,015k | Jun 30, 2019 | Aug 14, 2019 | |
| Ecor1 Capital LLC | 316,900 | $4,639k | Jun 30, 2019 | Aug 14, 2019 | |
| Baker BROS Advisors LP | 250,000 | $3,660k | Jun 30, 2019 | Aug 14, 2019 | |
| Pentwater Capital Management LP | 21,100 | $309k | Jun 30, 2019 | Aug 14, 2019 | |
| Dafna Capital Management LLC | 6,265 | $92k | Jun 30, 2019 | Aug 14, 2019 |